Table 2. The number of observed and hidden cases and prevalences in the total and non-screened population.
Total populationa | ObservedHCVcases | HiddenHCV cases(95%CI) | Prevalence(95%CI) | Prevalencehidden cases(95%CI) | ||
Sex | Male | 244,361 | 573 | 1,166 (838–1622) | 0.71% (0.58–0.90) | 0.48%(0.34–0.66) |
Female | 257,922 | 250 | 454 (275–748) | 0.27% (0.20–0.39) | 0.18%(0.11–0.29) | |
Sum | 1,620 (889–2951) | |||||
Ageb | 18–25 | 56,158 | 21 | 7 (2–24) | 0.05% (0.04–0.08) | 0.01%(0.00–0.04) |
26–35 | 65,627 | 159 | 269 (152–475) | 0.65% (0.47–0.97) | 0.41%(0.23–0.72) | |
36–45 | 95,970 | 352 | 764 (502–1162) | 1.16% (0.89–1.58) | 0.80%(0.52–1.21) | |
46–55 | 97,728 | 218 | 592 (284–1236) | 0.83% (0.51–1.49) | 0.61%(0.29–1.26) | |
56–65 | 84,322 | 47 | 45 (16–127) | 0.11% (0.07–0.21) | 0.05%(0.02–0.15) | |
>65 | 102,478 | 26 | 4 (2–10) | 0.03% (0.03–0.04) | 0.00%(0.00–0.01) | |
Sum | 1,681 (211–13,364) | |||||
SESsw | Low | 233,983 | 609 | 1073 (784–1468) | 0.72% (0.60–0.89) | 0.46%(0.34–0.63) |
Middle | 141,049 | 124 | 333 (156–711) | 0.32% (0.20–0.59) | 0.24%(0.11–0.50) | |
High | 127,250 | 90 | 170 (85–342) | 0.20% (0.14–0.34) | 0.13%(0.07–0.27) | |
Sum | 1,576 (537–4,626) | |||||
SESpv | Low | 224,326 | 542 | 977 (702–1358) | 0.68% (0.55–0.85) | 0.44%(0.31–0.61) |
Middle | 178,958 | 218 | 570 (322–1007) | 0.44% (0.30–0.68) | 0.32%(0.18–0.56) | |
High | 98,999 | 63 | 25 (9–71) | 0.09% (0.07–0.14) | 0.03%(0.01–0.07) | |
Sum | 1,596 (561–4,541) | |||||
Total | 502,283 | 823 | 1,621(1231–2135) | 0.49%(0.41–0.59) | 0.32%(0.25–0.43) |
Laboratory surveillance data, South Limburg, the Netherlands, 2002–2008.
Based on population statistics from 2007 [27].
Age at first positive test.
HCV: hepatitis C virus.
SESsw: Socio-economic status based on % of people receiving social welfare.
SESpv: Socio-economic status based on property value.